Table 3.
Selected treatment-emergent adverse events a (N = 52).
| Any gradeb (≥ 15%) |
Grade 3/4 | |
|---|---|---|
| Adverse event, no. (%) | ||
| Diarrhea | 25 (48.1) | 1 (1.9) |
| Fatigue | 18 (34.6) | 1 (1.9) |
| Nausea | 16 (30.8) | 2 (3.8) |
| Anemia | 15 (28.8) | 5 (9.6) |
| Thrombocytopenia | 15 (28.8) | 7 (13.5) |
| Neutropenia | 14 (26.9) | 11 (21.2) |
| Constipation | 13 (25.0) | 1 (1.9) |
| Vomiting | 12 (23.1) | |
| Headache | 11 (21.2) | 2 (3.8) |
| Peripheral edema | 9 (17.3) | 2 (3.8) |
| Hypokalemia | 9 (17.3) | 1 (1.9) |
| Arthralgia | 8 (15.4) |
a
Highest-frequency adverse events.
b
A patient with > 1 adverse event is counted once.